Effect of Nimodipine on Blood-Labyrinth Barrier Permeability Following Cochlear Ischemia/Reperfusion Injury in Guinea Pigs

Quan Boyuan,Qiu Jianhua,Liu Shunli

DOI: https://doi.org/10.3969/j.issn.1006-7299.2006.04.017

2006-01-01

Abstract:Objective To investigate the effect of intravenous application of nimodipine on blood-labyrinth barrier permeability following cochlear ischemia/reperfusion injury in guinea pigs.Methods The guinea pigs were randomly divided into four groups: nimodipine injection ischemia group (group A), saline injection ischemia group (group B), nimodipine injection reperfusion group (group C), and saline injection reperfusion group (group D). Thrombus formation upon the anterior inferior cerebral artery (AICA) induced by Fecl3 was used to develop the cochlear ischemia model in guinea pigs. Reperfusion was performed 1 hour after ischemia by intravenously injected Urokinase (UK). Nimodipine was intravenously injected in the early period of ischemia and after reperfusion. In saline groups, instead of nimodipine, saline injection was applied accordingly. The cochlear blood flow (CoBF) was monitored continuously with laser Doppler flowmeter. Threshold of auditory brainstem response (ABR) was measured before and after every experiment. The Evan's blue (EB) was intravenously injected at 2 h before the end of experiment in every group. The permeability of blood-labyrinth barrier was observed by the EB fluorescence quantitative method.Results Amount of EB passing through the blood-labyrinth barrier was (0.245±0.108)μg per guinea pig in group A, which was obviously decreased (P<0.05) as compared with group B(0.442±0.153)μg per guinea pig.Amount of EB passing through the blood-labyrinth barrier was(0.963±0.261)μg per guinea pig in group C, which was obviously increased (P<0.05) as compared with group D(0.620±0.148)μg per guinea pig.Conclusion Intravenous application of nimodipine in the early period of cochlear ischemia can alleviate the blood-labyrinth barrier damage and decrease its permeability. Intravenous application of nimodipine following cochlear reperfusion can accelerate the blood-labyrinth barrier damage and increase its permeability.